Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid (scientific article)

Q39604786	Antidiabetic effect of oleanolic acid: a promising use of a traditional pharmacological agent
Q37565304	Chaenomeles speciosa: A review of chemistry and pharmacology
Q36629854	Combining mTOR Inhibitors with Chemotherapy and Other Targeted Therapies in Advanced Breast Cancer: Rationale, Clinical Experience, and Future Directions
Q54349937	Managing postmenopausal women with hormone receptor-positive advanced breast cancer who progress on endocrine therapies with inhibitors of the PI3K pathway.
Q34479307	Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives.
Q50439143	Oleanolic Acid, a Compound Present in Grapes and Olives, Protects against Genotoxicity in Human Mammary Epithelial Cells.
Q39335047	Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells
Q60907443	Phytochemical and Pharmacological Properties of : An Edible Medicinal Chinese Mugua
Q35887473	Rapamycin induces the anti-apoptotic protein survivin in neuroblastoma.
Q35155622	Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer
Q37848652	The biological and therapeutic relevance of mRNA translation in cancer
Q35835218	The dual induction of apoptosis and autophagy by SZC014, a synthetic oleanolic acid derivative, in gastric cancer cells via NF-κB pathway